Jun 07, 2023 / 08:30PM GMT
Maury Raycroft - Jefferies LLC - Analyst
Hi, everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to introduce our guests today, Jon Stonehouse, the President and CEO of BioCryst and also John Bluth is with us as well. We're going to do fireside chat format. Thanks for joining us today.
Questions and Answers:
Maury Raycroft - Jefferies LLC - AnalystAnd maybe to start off, if Jon, you want to give a one minute intro to BioCryst?
Jon Stonehouse - BioCryst Pharmaceuticals, Inc. - President & CEO
Sure. Thanks, Maury, for inviting us in -- inviting us to your healthcare conference. So we're a company that develops -- discovers and develops, and commercializes small molecules for patients suffering from rare disease to give them the opportunity to have an oral drug. And it's a big deal for patients. It's not some incremental convenience improvement if they can take a once-a-day capsule. It has the effect of being like a daily vitamin and they forget their sex. They're